Perrigo has received final approval from the FDA to manufacture and market over-the-counter children's Cetirizine Hydrochloride Oral Solution for allergy and Cetirizine Hydrochloride Oral Solution for hives-relief, 1mg/mL.
Subscribe to our email newsletter
The product will be marketed under store brand labels and is comparable to McNeil Consumer Healthcare’s children’s Zyrtec Oral Solution, 1mg/mL, indicated for indoor and outdoor allergy and hives relief. The company expects to begin shipping the product immediately.
Joseph Papa, Perrigo’s chairman and CEO, said: “This approval reflects our strategy to be first to market with the important products that make quality healthcare more affordable for our customers.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.